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ABSTRACT
Objective: To study the effect of fast-food-based hyper-
alimentation on liver enzymes and hepatic triglyceride
content (HTGC).
Design: Prospective interventional study with parallel
control group.
Setting: University Hospital of Linko ¨ping, Sweden.
Participants: 12 healthy men and six healthy women
with a mean (SD) age of 26 (6.6) years and a matched
control group.
Intervention: Subjects in the intervention group aimed
for a body weight increase of 5–15% by eating at least
two fast-food-based meals a day with the goal to double
the regular caloric intake in combination with adoption of
a sedentary lifestyle for 4 weeks.
Main outcome measures: Weekly changes of serum
aminotransferases and HTGC measured by proton nuclear
magnetic resonance spectroscopy at baseline and after
the intervention.
Results: Subjects in the intervention group increased
from 67.6 (9.1) kg to 74.0 (11) kg in weight (p,0.001).
Serum ALT increased from 22.1 (11.4) U/l at study start
to an individual mean maximum level of 97 (103) U/l
(range 19.4–447 U/l). Eleven of the 18 subjects
persistently showed ALT above reference limits (women
.19 U/l, men .30 U/l) during the intervention. Sugar
(mono- and disaccharides) intake during week 3
correlated with the maximal ALT/baseline ALT ratio
(r=0.62, p=0.006). HTGC increased from 1.1 (1.9)% to
2.8 (4.8)%, although this was not related to the increase
in ALT levels. ALT levels were unchanged in controls.
Conclusion: Hyper-alimentation per se can induce
profound ALT elevations in less than 4 weeks. Our study
clearly shows that in the evaluation of subjects with
elevated ALT the medical history should include not only
questions about alcohol intake but also explore whether
recent excessive food intake has occurred.
Liver disease is often identified by asymptomatic
elevations in serum aminotransferases, as these are
commonly included in serum chemistry panels
drawn on healthy individuals. However, inciden-
tally discovered elevations of serum aminotrans-
ferases often lead to lengthy, expensive and
potentially invasive diagnostic evaluations.
Analysis of data from the Third National Health
and Nutrition Examination Survey (NHANES III)
in the United States showed a prevalence of
elevated alanine aminotransferase (ALT) or aspar-
tate aminotransferase (AST) to be as high as 7.9%.
1
This figure is considerably higher than the 1–4%
prevalence rate reported in earlier studies,
23 and
indicates that the prevalence of abnormal liver
tests in the general population has increased.
Although many cases of elevated aminotransferase
levels can be explained by the consumption of
large quantities of alcohol or the presence of
hepatitis C virus (HCV) infection, a great number
of cases typically remain unexplained.
1 In both
men and women, elevations of aminotransferases
are strongly associated with features of the
metabolic syndrome, such as abdominal adiposity,
high plasma glucose levels and dyslipidaemia,
4–7
Indeed, high serum levels of AST and ALT are
associated with future risk of developing type 2
diabetes.
8 Most cases of aminotransferase
elevations in seemingly healthy subjects have
hitherto generally been attributed to non-alcoholic
fatty liver disease (NAFLD),
19 and liver biopsy
studies of patients referred for aminotransferase
elevations have demonstrated liver steatosis as
the most common histological finding.
10–12 Interest-
ingly, it was recently shown that subjects with
NAFLD and elevated aminotransferases have a
significant risk of developing end-stage liver
disease and a lower chance of survival mainly
because of cardiovascular disease.
13 Accordingly,
the widespread misconception that NAFLD is a
mild disease with good prognosis has been high-
lighted
14 and it is likely that physicians will be
more concerned when facing patients with ele-
vated aminotransferases. However, in most asymp-
tomatic individuals with high aminotransferase
levels, the elevation is intermittent and normal
levels are found when testing is repeated within
months.
15 16
Although accumulation of triglycerides within
hepatocytes in NAFLD is a reversible process, it is
unlikely that steatosis is reversed rapidly without
any specific interventions and thus can explain
non-persistent aminotransferase elevations. More-
over, 79% of subjects with hepatic steatosis have
normal ALT levels
17 suggesting that conditions
other than fatty infiltration of the liver underlie
many cases of the asymptomatic elevations of
aminotransferases that are commonly found in the
general population.
We performed a study of the effects of 4 weeks
of fast-food-based hyper-alimentation on levels of
serum ALT and on hepatic triglyceride content
(HTGC) measured by proton nuclear magnetic
resonance spectroscopy (
1H-MRS). The aim of the
study was to investigate the potential link between
changes of serum ALT to the amount of hepatic
fatty infiltration in healthy non-obese subjects
Hepatology
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METHODS
Intervention group
By local advertising we recruited 12 men and six women as
volunteers for the intervention arm of the study. All subjects
except one were students, the majority of whom were medical
students. All participants had to be willing to accept an increase
in body weight of 5–15% and to eat at least two fast-food-based
meals a day, preferably at well known fast-food restaurants.
The cost for the food was consecutively reimbursed based on
the food receipts. Physical activity was not to exceed 5000 steps
per day. If a study subject reached a weight gain of 15% he or
she terminated the study as soon as possible by re-performing
the same study investigations as were done at baseline. The
participants were free from current diseases as judged by
medical check-up and history. Hepatitis B surface antigen
(HBsAg) and HCV antibodies were not detectable in any
subject. One of the participants had many years ago been
diagnosed with coeliac disease and underwent a duodenal
biopsy at the end of the study. This biopsy showed normal
duodenal histology.
All subjects in the intervention group continually had contact
with dieticians, by weekly meetings or by phone, during the
study. The dietary advice was individually adjusted to result in
an intake corresponding to doubling the present caloric
requirement. If the subject was not able or willing to ingest
the hamburger-based diet at any stage, it was changed to
whatever food the participant accepted with the highest
priority to achieve the calculated caloric intake and also, if the
study subject still found it acceptable, a diet rich in protein and
saturated animal fat. Habitual weekly alcohol consumption was
assessed at study entry and all subjects were asked to keep
alcohol intake unchanged during the study period. One of the
participants was an abstainer and one subject consumed 340 g/
week. The remaining 16 subjects reported an alcohol consump-
tion of ,140 g/week, which is the cut-off limit most often used
to set the diagnosis of NAFLD.
18
The composition of the diet was determined based on reports
from 3 days before the study and another two 3-day periods at
the end of the first or third weeks (or a week earlier in the one
subject who ended the trial after 2 weeks). Food items that
were bought in supermarkets to be consumed at less precise
time points, such as butter and other foodstuffs to mainly be
eaten at home, were averaged for the whole study period. In
most cases the exact food composition given by the correspond-
ing fast-food restaurant could be used as the source of
information, but if such information was incomplete, food
composition charts were used instead. The total caloric intake
was also determined for the whole study period, and was based
on receipts and interviews.
Blood for laboratory tests was drawn in the fasting state at
baseline, i.e. before starting on the extra caloric intake, after
2 weeks on the fast-food-based diet, and at the end of the study,
i.e. either at the end of fourth week or earlier if prematurely
terminated. Blood was also drawn in the non-fasting state at
the end of the first and the third study weeks, to monitor
changes in serum liver enzyme levels, and at long-term follow-
up after 6 months (in the fasting state) after the intervention,
analysed as described elsewhere.
19
Subjects of the intervention group underwent
1H-MRS of
HTGC
20 by using a Philips Achieva 1.5 T magnetic resonance
system (Philips Medical Systems, Best, The Netherlands) with a
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650 Gut 2008;57:649–654. doi:10.1136/gut.2007.131797single detection element of a four element SENSE body coil.
Localiser imaging for prescription of
1H-MRS from two different
volumes of interest (VOIs) were acquired using a balanced, fast
field echo pulse sequence. The
1H-MRS acquisition parameters
were: PRESS volume selection 20620620 mm
3 VOI, repetition
time = 3 s, echo time (TE) = 35 ms, dummy excitations = 2
and averages = 8). All spectral and imaging acquisitions
including preparation phases were performed during single
breath holds. Additional spectra using a TE of 50 ms were
acquired in a limited number of examinations for determination
of a correction factor for T2 relaxation of the lipid signal. A
correction factor for the T2 relaxation time of the liver water
signal was measured using an axially prescribed single slice
multi-echo turbo spin echo pulse sequence, (TE = 10, 20, 30,
40, 50 and 60 ms). Zero- and first-order phase corrections, a
10 Hz line broadening, and a least squares optimised spline
baseline correction were applied. The water and lipid resonances
were integrated from 6.0 to 3.3 ppm and 2.7 to 0.4 ppm,
respectively. The lipid volume fractions (HTGC) were calcu-
lated as previously described.
20 The upper limit of normal for
HTGC was based on the results by Szczepaniak et al
21 who
examined the distribution of HTGC with
1H-MRS in 345
subjects with a low risk for hepatic steatosis, i.e. BMI ,25 kg/
m
2, no glucose intolerance or excessive alcohol consumption and
normal serum ALT.
22 Hepatic steatosis was defined as an HTGC
greater than 5.6%, which corresponded to the 95
th percentile in
this low-risk group.
Basal metabolic rate was measured using a ventilated hood
technique (Delta Trac, SensorMedics, Yorba Linda, CA, USA)
23
in the fasting state in the morning and the mean value of one
measurement per minute during the last 6 min of a 15 min
period was calculated. The subjects were also subjected to dual
energy x ray absorptiometry (Hologic 4500, Hologic, Waltham,
MA, USA), for analysis of body composition. A biopsy of
subcutaneous abdominal fat was done under local anaesthesia
and non-invasive measurements of the vascular function were
recorded, the results of which will be reported separately. All the
investigations were performed at baseline and during the last
week of the study, except for the recording of basal metabolic
rate, which was also measured in the fasting state after 2 weeks
on the diet. All anthropometric measurements were done by
two research nurses.
Control group
An age- and gender-matched control group was also recruited
mainly to allow discrimination of changes of ALT induced by
food intake from random fluctuations. The control group
performed the laboratory investigations and anthropometric
measurements at baseline and after 4 weeks, as well as
measurement of basal metabolic rate.
Statistics
Statistical calculations were done with SPSS 14.0 software
(SPSS Inc. Chicago, IL, USA). Linear correlations were calcu-
lated, except as stated in the text. Comparisons within and
between groups were done with the Student paired and
unpaired two-tailed t test or as stated in the results section.
Mean (SD) is given unless otherwise stated. Statistical
significance was considered at the 5% level (p(0.05).
Ethics
The study was approved by the Ethics Committee of Linko ¨ping
University and performed in accordance with the Declaration of
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Gut 2008;57:649–654. doi:10.1136/gut.2007.131797 651Helsinki. Written informed consent was obtained from all
participating subjects.
RESULTS
Seventeen of the 18 participants met the goal of a 5–15%
increase in body weight by the intervention based on hyper-
alimentation combined with a sedentary life style. Table 1
shows baseline anthropometric and laboratory data of all the
participants, and the effects of the intervention.
The mean daily caloric intake of the whole intervention
period increased +70 (35)% (men +68 (31)%, women +74 (45)%,
p=0.8 for comparison of genders). Two men and two women
had a mean daily caloric intake .+90% of basal during the entire
study. There was no statistically significant change in the food
intake of macronutrients or fibre when comparing the registration
in the first and third weeks nor were there any gender differences
with regard to relative intake of macronutrients. Table 2 displays
food intake and the relative composition of the food before and
during the study in the intervention group.
Five of the 18 subjects in the intervention group reached the
maximal 15% increase in body weight (four men and one
woman). Three of these subjects reached the maximum weight
increase ahead of the last study week and subsequently stopped
the intervention prematurely. The subject with the steepest
increase in body weight was 80 kg at baseline and reached 92 kg
(+15%) after 2 weeks. The great majority of the participants
complained of epigastric discomfort and profound sense of
satiety during the first week, while the remaining weeks in most
cases were much more tolerable in this sense.
All subjects were informed of the test results on a weekly
basis, in particular ALT levels. Figure 1 displays the ALT levels
during the study in men and women. The one man who reached
the highest ALT after just 1 week of hyper-alimentation
(164 U/l, fig 1A) was a total abstainer from alcohol. One male
participant developed an ALT level of 447 U/l during the third
week, and thus was immediately returned to his regular eating
habits. However, there were no signs or symptoms of impaired
hepatic function (albumin, prothrombin time, alkaline phos-
phatase, AST and bilirubin were not affected) either in his case
or in the other participants that displayed particularly large
increases in ALT levels. Furthermore, the ALT elevations
subsided either during the study (fig 1) or within a few weeks
after the study had finished, in all cases. As shown in table 3
most participants developed pathological ALT levels during the
study. Long-term follow-up of ALT after 6 months displayed
similar levels as at baseline (baseline 22.4 (12) U/l, follow-up at
6 months 25.5 (22) U/l, p=0.4 in the paired t test, n=17, see
also table 3).
The increase in ALT was unrelated to the change in waist
circumference but tended to correlate with the weight increase
(ratio of ALT at study end/baseline ALT to the increase in
weight, r=0.42, p=0.085). The increase in caloric intake was
not correlated with changes in ALT levels (either change from
basal level to highest individual ALT, or to ALT change from
basal levels to those at study end) or HTGC. The average
consumption of fat or proteins during 3 days at the end of the
first or third weeks was unrelated to changes in ALT. However,
the maximal ALT/baseline ratio correlated with carbohydrate
intake during the third week (r=0.52, p=0.03, corresponding
figures for intake during week 1, r=0.40, p=0.1). The intake of
sugar (mono- and disaccharides) during week 3 also correlated
with the maximal ALT/baseline ALT ratio (intake during the
third week, r=0.62, p=0.006; corresponding figures for intake
at the end of the first week, r=0.45, p=0.06), but this
correlation was not independent of carbohydrate consumption
in a multivariate statistical model (data not shown).
HTGC increased from 1.1 (1.9)% to 2.8 (4.8)% in the
intervention group (p=0.003 by the Wilcoxon signed rank
test, table 1). The increase of HTGC did not correlate with the
increase in ALT (ratio of ALT at study end/baseline ALT to
HTGC at study end/baseline, p=0.11, Spearman) or intake of
fat, carbohydrates and protein. The increase in body weight
tended to relate to the increase in HTGC (r=0.44, p=0.07)
while the increase in the percentage of body fat was clearly
related to the increase in HTGC (r=0.81, p,0.001).
The control group displayed similar anthropometric data as
the intervention group but had statistically significantly higher
albumin throughout the study month. There was no change in
ALT levels in the control group and, as shown in table 1, the
baseline ALT was similar in the intervention and the control
groups while the difference at the study end between the two
groups was statistically significant (p=0.001).
DISCUSSION
The most important finding of this study was that during the
study period 13 subjects on the high caloric diet developed
pathological ALT, according to the updated definition of
healthy ranges.
22 In most subjects this elevation was evident
within the first week. Even when the higher levels used in
NHANES III
1 (31 and 40 U/l for women and men, respectively)
were considered as upper reference limits for ALT, eight and
nine subjects displayed elevated ALT after 1 and 4 weeks of
hyper-alimentation, respectively.
All except two subjects in the intervention group had HTGC
lower than 5.6% at the end of the study period, thus not
fulfilling current criteria for hepatic steatosis.
17 21 However, a
significant increase of HTGC occurred indicating a net retention
of lipids within hepatocytes. Thus, similar mechanisms that
underlie the pathogenesis of NAFLD may have been induced in
the intervention group, and at least partly explain the increased
serum ALT levels. Insulin resistance, which is one of the main
characteristicsof themetabolicsyndrome,isthemostreproducible
Table 3 Number of subjects in the intervention group displaying serum ALT above reference levels during the study and at follow-up
ALT reference levels
Baseline
(men n=12,
women n=6)
Week 1
(men n=12,
women n=6)
Week 2
(men n=12,
women n=6)
Week 3
(men n=11,
women n=6)
Week 4
(men n=11*,
women n=6)
Persistent elevation
from week 1 to
study end
Follow-up after
6 months
(n=17**)
Men .40 U/l{ 17 568 5 1
Men .30 U/l{{ 2 9 1 11 01 08 3
Women .31 U/l{ 02 332 1 0
Women .19 U/l{{ 15 434 3 2
*One subject that had returned to regular eating habits during the fourth week is included.
**One subject lost to follow-up due to studies abroad.
{Upper reference limits for ALT used in NHANES III.
1
{{Updated upper reference limits for ALT.
22
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7 Interestingly, insulin
resistance according to homeostasis model assessment (HOMA)
24
increased significantly in the intervention group during the study
period. Moreover, the dietary intervention also induced a visceral
accumulation of adipose tissue as shown by the significant
increase of waist circumference during the trial. Insulin resistance
leads to the accumulation of fat in hepatocytes by two main
mechanisms: lipolysis, particularly from visceral adipose tissue,
which increases fatty acid concentration in the portal circulation;
and hyperinsulinaemia, which leads to increased uptake of fatty
acids by the hepatocytes. The increase of fatty acids within
hepatocytes may have led to hepatocellular injury, depicted by
increased serum ALT in the participating subjects, through
multiple mechanisms (for a review see Angulo
18). It has recently
been suggested that hepatocellular injury in NAFLD may be
attributable to the combined effects of severe peripheral insulin
resistance and relative failure of humoral (adipokine) mediators
that combat the effect of high insulin levels on hepatic lipid
turnover.
25However,ALTlevelsincreasedalreadywithinaweek,a
time period after which a significant increase of lipids within
hepatocytes seems unlikely to have developed. Furthermore, the
magnitude of ALT elevation only tended tocorrelatewith those of
HTGC, making it unlikely that fatty infiltration of the liver was
the main cause of the rapidly increased ALT levels that were
evident in many subjects. Hepatocellular damage due to other
reasons than intracellular accumulation of lipids, for example
localised inflammation, could potentially explainthe elevatedALT
levels. Indeed, when examining the relationship of the increase in
ALT to intake of different nutrients, fat intake was unrelated to
increase in ALT while sugar and carbohydrate intake at week 3
clearly related to the ALT increase. This is in accordance with
earlier findings by Solga et al who demonstrated that higher
carbohydrate intake was significantly associated with an increased
risk of biopsy-proven hepatic inflammation in morbidly obese
patients undergoing bariatric surgery.
26 Several participants
displayed a spontaneous decrease of ALT levels after the initial
increase, during the study, while still gaining weight by the
intervention, which is surprising if inflammation was the major
mediator of the ALT increase. We believe that a plausible
explanation for the ALT elevations in this study may be that the
sudden increased supply of metabolic substrates, to the liver, in
particular monosaccharides, caused an enzymatic induction in
hepatocytes and hence that the normal leakage of ALT through
the cell membrane resulted in elevated serum levels. The fact that
bilirubin levels decreased in the intervention group is in line with
induction of hepatic metabolic capacity rather than frank liver cell
damage.
Close clinical follow-up has been suggested as the most cost-
effective strategy for asymptomatic patients with negative tests
for viral, metabolic and autoimmune markers of liver disease
and chronically elevated aminotransferase levels. If the levels are
spontaneously normalised or only intermittently elevated, no
further evaluation is usually undertaken. However, in many
cases high alcohol consumption is suspected even though short-
term ingestion of alcohol in healthy individuals has not been
shown to be associated with clinical significant increases of
aminotransferases.
27 28 Interestingly, in a study by Belfrage et al
daily ingestion of 63 g alcohol for 5 weeks induced fatty
infiltration of the liver but not elevations of aminotransferases.
29
In comparison, our study showed that 4 weeks of hyper-
alimentation is associated with clinically significant elevations
of aminotransferases in many subjects but with development of
hepatic steatosis in just one subject out of 18.
The major weakness of our study is that subjects did not
undergo liver biopsy to confirm the absence of hepatic
pathology at baseline. However, 15 of 18 subjects had normal
Figure 1 ALT levels at baseline and
during the study in men (A, n=12) and
women (B, n=6) of the intervention
group.
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22 and all
subjects except one had HTGC well below the level considered
to be abnormal, i.e. 5.6%,
21 and none had antibodies indicative
of viral hepatitis. Thus, underlying liver disease is unlikely
among the participating subjects. One subject with an HTGC of
8.7% reported an average weekly alcohol consumption of 340 g,
and thus he was considered to have alcoholic steatosis.
However, his baseline ALT was also normal (21 U/l) according
to the updated definitions. Due to the demanding and unusual
nature of the trial it was not possible to recruit enough potential
intervention participants to allow randomisation to the inter-
vention or control groups. It should also be noted that the
participants were not representative of the general Swedish
citizen, as displayed, for example, by the high baseline fibre
intake, and of course by inclusion of only lean subjects.
Although the levels of serum aminotransferases were the same
in controls and in the subjects of the intervention group at
baseline, we were not able to analyse this in relation to the diet
composition in the controls, since this was not recorded.
Automated routine laboratory testing is frequently part of an
annual check-up and physicians are often faced with the
problem of a patient with abnormal result on measurement of
serum ALT but no symptoms. We conclude that chronically or
intermittently elevated ALT can be of purely nutritional origin,
particularly when found in the absence of liver steatosis. The
fact that 14 out of 18 participants had pathological ALT levels
after just 1 week clearly displays that elevated ALT levels after a
short over-indulgent holiday can be caused not only by alcohol
ingestion, but also by a higher caloric intake than usual
combined with a sedentary behaviour. We suggest that in the
clinical evaluation of subjects with elevated ALT physicians
should include not only questions about alcohol intake, but also
explore whether recent excessive food intake has occurred.
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